|Allos Therapeutics||United States, Westminster|
|Xiamen Dingsheng Zhicheng||China, Xiamen|
|Sarwa Capital||Egypt, Cairo|
|Growth Circuit||United States, San Francisco|
|Divine Capital Management||China, Shenzhen|
|Pine Labs||India, Noida|
|Pepper Group||Australia, North Sydney|
|Hybrid Capital||United States, New York|
|Platform Partners||United States, Houston|
|Prologis Ventures||United States, San Francisco|
|Moxxie Ventures||United States, San Francisco|
|PICC Property and Casualty||China, Hong Kong Island|
|IMM Private Equity||South Korea, Seoul|
|Obvious Ventures||United States, San Francisco|
|01 Aug 2015||United States, New York|
1. You post comments at your own choice and risk. You bear the whole responsibility,related to their substance, content and the fact of publication. We shall not bear anyliability in respect of such comments.
2. While commenting, you shall use only actual, truthful and confirmed data. In thesame time you shall not use vulgar, abusive or defamatory language as well as expresshatred or call to violence or cruelty.
3. We do not intend to delete any comments on the website unless within our “noticeand take down” procedure.
4. We can moderate comments at any time.
6. We retain our right to delete any comment or any other content of the website at ourwill in case we know or suppose such content is illegal or breaches any lawful right.
- No reviews are submitted yet.
Sign up and get access to full fund profile and advanced analysis.